Viewing StudyNCT00081068



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00081068
Status: WITHDRAWN
Last Update Posted: 2013-01-08
First Post: 2004-04-07

Brief Title: Alemtuzumab in Treating Patients With Waldenstroms Macroglobulinemia
Sponsor: Jonsson Comprehensive Cancer Center
Organization: Jonsson Comprehensive Cancer Center

Organization Data

Organization: Jonsson Comprehensive Cancer Center
Class: OTHER
Study ID: CDR0000358811
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Jonsson Comprehensive Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH